Lithium Controlled-Release and Extended-Release Tablets and Remodulin
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Remodulin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: treprostinil
Brand name: Remodulin, Orenitram, Tyvaso, Tyvaso Refill Kit, Tyvaso Starter Kit
Synonyms: Remodulin (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Remodulin injection
- Lithium Controlled-Release and Extended-Release Tablets-Remular-S
- Lithium Controlled-Release and Extended-Release Tablets-Renacidin
- Lithium Controlled-Release and Extended-Release Tablets-Renagel
- Lithium Controlled-Release and Extended-Release Tablets-Renal Caps
- Lithium Controlled-Release and Extended-Release Tablets-RenAmin
- Remodulin-Lithium ER
- Remodulin-Lithium Oral Solution
- Remodulin-Lithium Salts
- Remodulin-Lithium Syrup and Oral Solution
- Remodulin-Lithobid
- Remodulin-Lithostat